Christopher Dougherty
Werdegang
Berufserfahrung von Christopher Dougherty
- Current 18 years and 5 months, since 2008
Chief Scientific Officer
OncoMune
Chief Scientific Officer at OncoMune directing the development of three different novel approaches to cancer therapy (DNA vaccines, siRNA inhibitors & small molecules) through pre-clinical and clinical development. All of these technologies target the epigenetic-acting cancer-causing transcription factor, BORIS (Brother Of the Regulator of Imprinted Sites) which has been identified in all cancers tested to date.
- Current 20 years and 4 months, since Feb 2006
Research Assistant Professor of Biomedical Science
Florida Atlantic University
Design, construction, purification and testing of tissue-specific condtionally-regulated gene therapy vectors based on an Adeno-Associated Virus (AAV) platform. Designed gene therapies for Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Vascular Permeability, Parkinson's Disease and several cancers.
Ausbildung von Christopher Dougherty
- 5 years and 10 months, Aug 1996 - May 2002
Molecular & Cellular Pharmacology
University of Miami Miller School of Medicine
Oxidative stress, hypoxia, ischemia, reoxygenation-mediated apoptosis, growth factors, MAPKs, signal transduction, regulated gene therapy, pharmacology, molecular biology.
Sprachen
English
XING Mitglieder mit ähnlichen Profilangaben
XING – Das Jobs-Netzwerk
Über eine Million Jobs
Entdecke mit XING genau den Job, der wirklich zu Dir passt.
Persönliche Job-Angebote
Lass Dich finden von Arbeitgebern und über 20.000 Recruiter·innen.
21 Mio. Mitglieder
Knüpf neue Kontakte und erhalte Impulse für ein besseres Job-Leben.
Kostenlos profitieren
Schon als Basis-Mitglied kannst Du Deine Job-Suche deutlich optimieren.